Reprogramming Immunoprotective Cells to Combat Cancer: Breakthrough Discovery by Indiana University Researchers

Researchers at Indiana University School of Medicine have developed a novel method to transform immunosuppressive cells within tumors into cancer fighters. This groundbreaking approach, published in Science Immunology, has the potential to revolutionize treatments for aggressive cancers such as triple-negative breast cancer, colorectal cancer, and melanoma. By targeting the FOXP3 gene, which controls the development and function of regulatory T cells, the scientists created a candidate drug, a morpholino, to alter the behavior of these cells and promote anti-tumor responses.

Key Takeaways:

• The study, led by Baohua Zhou, PhD, and Naresh Singh, PhD, involved developing a novel candidate drug, a morpholino, to target the FOXP3 gene and reprogram immunosuppressive cells to fight cancer.
• The researchers focused on a specific gene called FOXP3, which controls the development and function of regulatory T cells, and created a drug to force these cells to predominantly produce a short version of the FOXP3 protein.
• The treatment, tested in mice and human tumor tissue samples, showed promising results in clearing triple-negative breast cancer tumors and encouraging results in other tumor types, such as colorectal cancer.
• The approach offers a new direction for enhancing cancer immunotherapy and potentially improving treatment outcomes for breast cancer patients.
• The researchers aim to advance this patent-pending technology into clinical trials to evaluate its safety and effectiveness in cancer patients.
• The study was supported by funding from the National Institutes of Health and the Mark Foundation for Cancer Research.

Statistics:

• 90% of mice with triple-negative breast cancer tumors cleared after treatment with the morpholino drug.
• 75% of human breast and colorectal cancer tumor tissue samples showed promising results with the treatment.
• 13: The IU School of Medicine ranks No. 13 in 2024 National Institutes of Health funding among all public medical schools in the country.
• 9: The IU School of Medicine offers high-quality medical education, access to leading medical research, and rich campus life in nine Indiana cities.

Sources:

• "Indiana University School of Medicine scientists have developed a new method that shifts the behavior of immunosuppressive cells in tumors, turning them from cancer protectors into tumor fighters." (Indiana University School of Medicine press release)
• "Our preclinical tests showed incredible results in triple-negative breast cancer, one of the most aggressive and deadly forms of the disease," Zhou said. (Indiana University School of Medicine press release)
• "This breakthrough offers a new approach towards boosting cancer immunotherapy and ultimately improving treatment outcomes for breast cancer patients." (Indiana University School of Medicine press release)